Short answer
Outset Medical, Inc. (OM) filed an 8-K current report with the SEC on August 6, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q2 2026 earnings release covers the quarter ended June 30, 2026.
Outset Medical, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 earnings release covers the quarter ended June 30, 2026
- Press release furnished as Exhibit 99.1 contains the financial results and management commentary
- Earnings conference call scheduled for August 6, 2026
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $31.6M, up 1% YoY and 14% sequentially, indicating modest growth acceleration
- Gross margin expanded to 42.0% from 37.8%; service margin surged to 32.6% from 6.9%
- HCA Healthcare agreement worth $40M over three years improves backlog visibility and supports Tablo fleet refresh demand
- Net loss narrowed to $18.0M from $18.5M; cash burn $9.5M in Q2 against $151M total liquidity
- 2026 revenue guidance maintained at $125M-$130M, with non-GAAP gross margin expected in the low-40% to mid-40% range
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Outset Medical, Inc. 8-K filings
Get the next OM 8-K as it lands
Follow OM for push alerts, or ask the research agent what this filing means.